Cargando…

PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION

INTRO: The COVID-19 pandemic is caused by the SARS-CoV-2 virus, an enveloped RNA of the coronavirus family. The advancement in molecular technology and biochemistry has accelerated the development of diagnostic reagents and assays. Much attention has been focused on the S protein, but the high mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahim, N.A. Mat, Zahidi, J., Hashim, N.A. Amir, Amdan, N.A. Nor, Zamri, H.F., Ali, M.R. Mohd, Zain, R. Mohd, Ahmad, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186896/
http://dx.doi.org/10.1016/j.ijid.2023.04.342
_version_ 1785042644695515136
author Rahim, N.A. Mat
Zahidi, J.
Hashim, N.A. Amir
Amdan, N.A. Nor
Zamri, H.F.
Ali, M.R. Mohd
Zain, R. Mohd
Ahmad, N.
author_facet Rahim, N.A. Mat
Zahidi, J.
Hashim, N.A. Amir
Amdan, N.A. Nor
Zamri, H.F.
Ali, M.R. Mohd
Zain, R. Mohd
Ahmad, N.
author_sort Rahim, N.A. Mat
collection PubMed
description INTRO: The COVID-19 pandemic is caused by the SARS-CoV-2 virus, an enveloped RNA of the coronavirus family. The advancement in molecular technology and biochemistry has accelerated the development of diagnostic reagents and assays. Much attention has been focused on the S protein, but the high mutation rate in this region could lead to false negative results. Thus, a better target protein for diagnostic application is needed for accurate detection. METHODS: Nucleotide sequences encoded for membrane (M) glycoprotein gene region of SARS-CoV-2 from Malaysian isolates were extracted from GISAID, aligned, and selected accordingly. The DNA plasmid was commercially synthesized with codon optimization for Escherichia coli (E. coli), and the presence of the M gene was confirmed by PCR. The plasmid was then transformed into E. coli. Later, the expression of M glycoprotein was induced, separated on an SDS-PAGE gel, and transferred onto a nitrocellulose membrane, followed by immunostaining. FINDINGS: The analysis of the M glycoprotein against the Omicron strains demonstrated that the amino acid is conserved (99.5%). The M glycoprotein was successfully expressed and detected with antibodies from SARS-CoV-2 infected patients at ∼26 kDa. The protein is currently upscale for the generation of monoclonal Ab (Mab). DISCUSSION: The M protein of SARS-CoV-2 is more conserved among the virus and also has been reported to confer antigenic properties. Selection of M protein perhaps a better option compared to current detection assays that use spike (S) protein, which could lead to false negative results, as this gene region particularly the ribosome-binding domain (RBD) rapidly undergoes mutations. The utilization of M protein potentially improves negative predictive value (NPV) of the diagnostic test. CONCLUSION: Further development of diagnostic reagents is needed to improve the assay's specificity. The newly developed M protein and the MAb can be used to generate a more accurate viral detection assay.
format Online
Article
Text
id pubmed-10186896
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-101868962023-05-16 PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION Rahim, N.A. Mat Zahidi, J. Hashim, N.A. Amir Amdan, N.A. Nor Zamri, H.F. Ali, M.R. Mohd Zain, R. Mohd Ahmad, N. Int J Infect Dis Article INTRO: The COVID-19 pandemic is caused by the SARS-CoV-2 virus, an enveloped RNA of the coronavirus family. The advancement in molecular technology and biochemistry has accelerated the development of diagnostic reagents and assays. Much attention has been focused on the S protein, but the high mutation rate in this region could lead to false negative results. Thus, a better target protein for diagnostic application is needed for accurate detection. METHODS: Nucleotide sequences encoded for membrane (M) glycoprotein gene region of SARS-CoV-2 from Malaysian isolates were extracted from GISAID, aligned, and selected accordingly. The DNA plasmid was commercially synthesized with codon optimization for Escherichia coli (E. coli), and the presence of the M gene was confirmed by PCR. The plasmid was then transformed into E. coli. Later, the expression of M glycoprotein was induced, separated on an SDS-PAGE gel, and transferred onto a nitrocellulose membrane, followed by immunostaining. FINDINGS: The analysis of the M glycoprotein against the Omicron strains demonstrated that the amino acid is conserved (99.5%). The M glycoprotein was successfully expressed and detected with antibodies from SARS-CoV-2 infected patients at ∼26 kDa. The protein is currently upscale for the generation of monoclonal Ab (Mab). DISCUSSION: The M protein of SARS-CoV-2 is more conserved among the virus and also has been reported to confer antigenic properties. Selection of M protein perhaps a better option compared to current detection assays that use spike (S) protein, which could lead to false negative results, as this gene region particularly the ribosome-binding domain (RBD) rapidly undergoes mutations. The utilization of M protein potentially improves negative predictive value (NPV) of the diagnostic test. CONCLUSION: Further development of diagnostic reagents is needed to improve the assay's specificity. The newly developed M protein and the MAb can be used to generate a more accurate viral detection assay. Published by Elsevier Ltd. 2023-05 2023-05-16 /pmc/articles/PMC10186896/ http://dx.doi.org/10.1016/j.ijid.2023.04.342 Text en Copyright © 2023 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rahim, N.A. Mat
Zahidi, J.
Hashim, N.A. Amir
Amdan, N.A. Nor
Zamri, H.F.
Ali, M.R. Mohd
Zain, R. Mohd
Ahmad, N.
PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION
title PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION
title_full PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION
title_fullStr PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION
title_full_unstemmed PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION
title_short PRODUCTION OF SARS-COV-2 MEMBRANE PROTEIN AS BETTER TARGET PROTEIN FOR DIAGNOSTIC APPLICATION
title_sort production of sars-cov-2 membrane protein as better target protein for diagnostic application
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186896/
http://dx.doi.org/10.1016/j.ijid.2023.04.342
work_keys_str_mv AT rahimnamat productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication
AT zahidij productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication
AT hashimnaamir productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication
AT amdannanor productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication
AT zamrihf productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication
AT alimrmohd productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication
AT zainrmohd productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication
AT ahmadn productionofsarscov2membraneproteinasbettertargetproteinfordiagnosticapplication